Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd signed Share Transfer Agreement to acquire 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) from Changxing Shengshi Fenghua Business Co., Ltd. for CNY 154.14 million on June 14, 2023. The price per share is CNY 7.34 for 21 million shares of Changjiang Pharmaceutical Group Co., Ltd. This share transfer still needs to pass the compliance review of the Shenzhen Stock Exchange and go through the relevant procedures for share transfer at the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 CNY | -4.57% | +3.93% | -48.71% |
Apr. 09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
Apr. 01 | Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.71% | 192M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300391 Stock
- News Changjiang Pharmaceutical Group Co., Ltd.
- Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd signed Share Transfer Agreement to acquire 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd. for CNY 154.14 million.